Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kui-Yuan Chewable Tablets in Hyperuricemia
NCT05913310Phase 4Unknown
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Kui-Yuan in hyperuricemia. Status: unknown.
02
Drugs
Kui-Yuan
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT05913310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05913310.